ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,930, issued on Oct. 6, was assigned to City of Hope (Duarte, Calif.).
"Cell-receptor targeted exosomes" was invented by Kevin Morris (Duarte, Calif.) and Tristan Scott (Duarte, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are, inter alia, recombinant fusion proteins and exosomes comprising recombinant fusion proteins; wherein the recombinant fusion proteins comprises exosome membrane-associated proteins and exogenous target proteins; pharmaceutical compositions; and methods of using the recombinant fusion proteins, exosomes, and pharmaceutical compositions to treat diseases such as cancer, HIV, and COVID-19."
The patent was ...